Rev revisited: Additional functions of the HIV-1 rev protein

Recent Advances in Human Retroviruses: Principles of Replication and Pathogenesis: Advances in Retroviral Research

Volumn , Issue , 2010, Pages 439-470

  Grewe, Bastian ^a   Überla, Klaus ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84971224758     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789814295314_0014     Document Type: Chapter

References (113)

1. Arnold M, Nath A, Hauber J, et al. (2006) Multiple importins function as nuclear transport receptors for the Rev protein of human immunodeficiency virus type 1. J Biol Chem 281: 20883–20890.
2. Cullen BR. (2003) Nuclear mRNA export: Insights from virology. Trends Biochem Sci 28: 419–424.
3. Cochrane AW, McNally MT, Mouland AJ. (2006) The retrovirus RNA trafficking granule: From birth to maturity. Retrovirology 3: 18.
4. Huang Y, Carmichael GG. (1996) Role of polyadenylation in nucleocytoplasmic transport of mRNA. Mol Cell Biol 16: 1534–1542.
5. McLaren M, Asai K, Cochrane A. (2004) A novel function for Sam68: Enhancement of HIV-1 RNA 3' end processing. RNA 10: 1119–1129.
6. McLaren M, Marsh K, Cochrane A. (2008) Modulating HIV-1 RNA processing and utilization. Front Biosci 13: 5693–5707.
7. Iacampo S, Cochrane A. (1996) Human immunodeficiency virus type 1 Rev function requires continued synthesis of its target mRNA. J Virol 70: 8332–8339.
8. Pollard VW, Malim MH. (1998) The HIV-1 Rev protein. Annu Rev Microbiol 52: 491–532.
9. Chang DD, Sharp PA. (1989) Regulation by HIV Rev depends upon recognition of splice sites. Cell 59: 789–795.
10. Tange TO, Jensen TH, Kjems J. (1996) In vitro interaction between human immunodeficiency virus type 1 Rev protein and splicing factor ASF/SF2- associated protein, p32. J Biol Chem 271: 10066–10072.
11. Zheng YH, Yu HF, Peterlin BM. (2003) Human p32 protein relieves a posttranscriptional block to HIV replication in murine cells. Nat Cell Biol 5: 611–618.
12. Powell DM, Amaral MC, Wu JY, et al. (1997) HIV Rev-dependent binding of SF2/ASF to the Rev response element: Possible role in Rev-mediated inhibition of HIV RNA splicing. Proc Natl Acad Sci USA 94: 973–978.
13. Kjems J, Frankel AD, Sharp PA. (1991) Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev. Cell 67: 169–178.
14. Hope TJ. (1999) The ins and outs of HIV Rev. Arch Biochem Biophys 365: 186–191.
15. Kammler S, Otte M, Hauber I, et al. (2006) The strength of the HIV-1 3' splice sites affects Rev function. Retrovirology 3: 89.
16. O’Reilly MM, McNally MT, Beemon KL. (1995) Two strong 5' splice sites and competing, suboptimal 3' splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA. Virology 213: 373–385.
17. Si Z, Amendt BA, Stoltzfus CM. (1997) Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2. Nucl Acid Res 25: 861–867.
18. Staffa A, Cochrane A. (1994) The tat/rev intron of human immunodeficiency virus type 1 is inefficiently spliced because of suboptimal signals in the 3' splice site. J Virol 68: 3071–3079.
19. Hammarskjold ML, Li H, Rekosh D, et al. (1994) Human immunodeficiency virus env expression becomes Rev-independent if the env region is not defined as an intron. J Virol 68: 951–958.
20. Graf M, Ludwig C, Kehlenbeck S, et al. (2006) A quasi-lentiviral green fluorescent protein reporter exhibits nuclear export features of late human immunodeficiency virus type 1 transcripts. Virology 352: 295–305.
21. Lu XB, Heimer J, Rekosh D, et al. (1990) U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced. Proc Natl Acad Sci USA 87: 7598–7602.
22. Brighty DW, Rosenberg M. (1994) A cis-acting repressive sequence that overlaps the Rev-responsive element of human immunodeficiency virus type 1 regulates nuclear retention of env mRNAs independently of known splice signals. Proc Natl Acad Sci USA 91: 8314–8318.
23. Cochrane AW, Jones KS, Beidas S, et al. (1991) Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J Virol 65: 5305–5313.
24. Maldarelli F, Martin MA, Strebel K. (1991) Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: Novel level of gene regulation. J Virol 65: 5732–5743.
25. Mikaelian I, Krieg M, Gait MJ, et al. (1996) Interactions of INS (CRS) elements and the splicing machinery regulate the production of Rev-responsive mRNAs. J Mol Biol 257: 246–264.
26. Nasioulas G, Zolotukhin AS, Tabernero C, et al. (1994) Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA. J Virol 68: 2986–2993.
27. Schwartz S, Campbell M, Nasioulas G, et al. (1992) Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J Virol 66: 7176–7182.
28. Schwartz S, Felber BK, Pavlakis GN. (1992) Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. J Virol 66: 150–159.
29. Seguin B, Staffa A, Cochrane A. (1998) Control of human immunodeficiency virus type 1 RNA metabolism: Role of splice sites and intron sequences in unspliced viral RNA subcellular distribution. J Virol 72: 9503–9513.
30. Suh D, Seguin B, Atkinson S, et al. (2003) Mapping of determinants required for the function of the HIV-1 env nuclear retention sequence. Virology 310: 85–99.
31. Afonina E, Neumann M, Pavlakis GN. (1997) Preferential binding of poly(A)-binding protein 1 to an inhibitory RNA element in the human immunodeficiency virus type 1 gag mRNA. J Biol Chem 272: 2307–2311.
32. Najera I, Krieg M, Karn J. (1999) Synergistic stimulation of HIV-1 revdependent export of unspliced mRNA to the cytoplasm by hnRNP A1. J Mol Biol 285: 1951–1964.
33. Olsen HS, Cochrane AW, Rosen C. (1992) Interaction of cellular factors with intragenic cis-acting repressive sequences within the HIV genome. Virology 191: 709–715.
34. Zolotukhin AS, Michalowski D, Bear J, et al. (2003) PSF acts through the human immunodeficiency virus type 1 mRNA instability elements to regulate virus expression. Mol Cell Biol 23: 6618–6630.
35. Schneider R, Campbell M, Nasioulas G, et al. (1997) Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Revindependent expression of Gag and Gag/protease and particle formation. J Virol 71: 4892–4903.
36. Graf M, Bojak A, Deml L, et al. (2000) Concerted action of multiple cisacting sequences is required for Rev dependence of late human immunodeficiency virus type 1 gene expression. J Virol 74: 10822–10826.
37. Haas J, Park EC, Seed B. (1996) Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr Biol 6: 315–324.
38. Kotsopoulou E, Kim VN, Kingsman AJ, et al. (2000) A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J Virol 74: 4839–4852.
39. Wagner R, Graf M, Bieler K, et al. (2000) Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: Implications for the safety of lentiviral vectors. Hum Gene Ther 11: 2403–2413.
40. Arrigo SJ, Chen IS. (1991) Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Genes Dev 5: 808–819.
41. Arrigo SJ, Weitsman S, Rosenblatt JD, et al. (1989) Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method. J Virol 63: 4875–4881.
42. Coyle JH, Guzik BW, Bor YC, et al. (2003) Sam68 enhances the cytoplasmic utilization of intron-containing RNA and is functionally regulated by the nuclear kinase Sik/BRK. Mol Cell Biol 23: 92–103.
43. D’Agostino DM, Felber BK, Harrison JE, et al. (1992) The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs. Mol Cell Biol 12: 1375–1386.
44. Guzik BW, Levesque L, Prasad S, et al. (2001) NXT1 (p15) is a crucial cellular cofactor in TAP-dependent export of intron-containing RNA in mammalian cells. Mol Cell Biol 21: 2545–2554.
45. Wodrich H, Schambach A, Krausslich HG. (2000) Multiple copies of the Mason-Pfizer monkey virus constitutive RNA transport element lead to enhanced HIV-1 Gag expression in a context-dependent manner. Nucl Acid Res 28: 901–910.
46. Yi R, Bogerd HP, Cullen BR. (2002) Recruitment of the Crm1 nuclear export factor is sufficient to induce cytoplasmic expression of incompletely spliced human immunodeficiency virus mRNAs. J Virol 76: 2036–2042.
47. Favaro JP, Arrigo SJ. (1997) Characterization of Rev function using subgenomic and genomic constructs in T and COS cells. Virology 228: 29–38.
48. Favaro JP, Maldarelli F, Arrigo SJ, et al. (1999) Effect of rev on the cytoplasmic localization of intron-containing human immunodeficiency virus type 1 RNA. Virology 255: 237–249.
49. Kimura T, Hashimoto I, Nishikawa M, et al. (1996) A role for Rev in the association of HIV-1 gag mRNA with cytoskeletal beta-actin and viral protein expression. Biochimie 78: 1075–1080.
50. Perales C, Carrasco L, Gonzalez ME. (2005) Regulation of HIV-1 env mRNA translation by Rev protein. Biochim Biophys Acta 1743: 169–175.
51. Felber BK, Hadzopoulou-Cladaras M, Cladaras C, et al. (1989) Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc Natl Acad Sci USA 86: 1495–1499.
52. Malim MH, Cullen BR. (1993) Rev and the fate of pre-mRNA in the nucleus: Implications for the regulation of RNA processing in eukaryotes. Mol Cell Biol 13: 6180–6189.
53. Malim MH, Hauber J, Fenrick R, et al. (1988) Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes. Nature 335: 181–183.
54. Malim MH, Hauber J, Le SY, et al. (1989) The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338: 254–257.
55. Jin L, Guzik BW, Bor YC, et al. (2003) Tap and NXT promote translation of unspliced mRNA. Genes Dev 17: 3075–3086.
56. Izaurralde E, Mattaj IW. (1995) RNA export. Cell 81: 153–159.
57. Kohler A, Hurt E. (2007) Exporting RNA from the nucleus to the cytoplasm. Nat Rev Mol Cell Biol 8: 761–773.
58. Nakielny S, Fischer U, Michael WM, et al. (1997) RNA transport. Annu Rev Neurosci 20: 269–301.
59. Emerman M, Vazeux R, Peden K. (1989) The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization. Cell 57: 1155–1165.
60. Soros VB, Carvajal HV, Richard S, et al. (2001) Inhibition of human immunodeficiency virus type 1 Rev function by a dominant-negative mutant of Sam68 through sequestration of unspliced RNA at perinuclear bundles. J Virol 75: 8203–8215.
61. Cmarko D, Boe SO, Scassellati C, et al. (2002) Rev inhibition strongly affects intracellular distribution of human immunodeficiency virus type 1 RNAs. J Virol 76: 10473–10484.
62. Butsch M, Hull S, Wang Y, et al. (1999) The 5' RNA terminus of spleen necrosis virus contains a novel posttranscriptional control element that facilitates human immunodeficiency virus Rev/RRE-independent Gag production. J Virol 73: 4847–4855.
63. Campbell LH, Borg KT, Haines JK, et al. (1994) Human immunodeficiency virus type 1 Rev is required in vivo for binding of poly(A)-binding protein to Rev-dependent RNAs. J Virol 68: 5433–5438.
64. Lawrence JB, Cochrane AW, Johnson CV, et al. (1991) The HIV-1 Rev protein: A model system for coupled RNA transport and translation. New Biol 3: 1220–1232.
65. Elroy-Stein O, Moss B. (1990) Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells. Proc Natl Acad Sci USA 87: 6743–6747.
66. Blissenbach M, Grewe B, Hoffmann B, et al. (2010) Nuclear RNA export and packaging functions of HIV-1 Rev revisited. J Virol (in press).
67. Nam YS, Petrovic A, Jeong KS, et al. (2001) Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation. J Virol 75: 2957–2971.
68. Bray M, Prasad S, Dubay JW, et al. (1994) A small element from the Mason- Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc Natl Acad Sci USA 91: 1256–1260.
69. Ernst RK, Bray M, Rekosh D, et al. (1997) A structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNA. Mol Cell Biol 17: 135–144.
70. Gruter P, Tabernero C, von Kobbe C, et al. (1998) TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus. Mol Cell 1: 649–659.
71. Pasquinelli AE, Ernst RK, Lund E, et al. (1997) The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J 16: 7500–7510.
72. Zolotukhin AS, Valentin A, Pavlakis GN, et al. (1994) Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes. J Virol 68: 7944–7952.
73. Smulevitch S, Bear J, Alicea C, et al. (2006) RTE and CTE mRNA export elements synergistically increase expression of unstable, Rev-dependent HIV and SIV mRNAs. Retrovirology 3: 6.
74. Nappi F, Schneider R, Zolotukhin A, et al. (2001) Identification of a novel posttranscriptional regulatory element by using a rev- and RRE-mutated human immunodeficiency virus type 1 DNA proviral clone as a molecular trap. J Virol 75: 4558–4569.
75. Wodrich H, Bohne J, Gumz E, et al. (2001) A new RNA element located in the coding region of a murine endogenous retrovirus can functionally replace the Rev/Rev-responsive element system in human immunodeficiency virus type 1 Gag expression. J Virol 75: 10670–10682.
76. von Gegerfelt AS, Liska V, Ray NB, et al. (1999) Persistent infection of rhesus macaques by the rev-independent Nef(-) simian immunodeficiency virus SIVmac239: Replication kinetics and genomic stability. J Virol 73: 6159–6165.
77. Hartman TR, Qian S, Bolinger C, et al. (2006) RNA helicase A is necessary for translation of selected messenger RNAs. Nat Struct Mol Biol 13: 509–516.
78. Hull S, Boris-Lawrie K. (2002) RU5 of Mason-Pfizer monkey virus 5' long terminal repeat enhances cytoplasmic expression of human immunodeficiency virus type 1 gag-pol and nonviral reporter RNA. J Virol 76: 10211–10218.
79. Roberts TM, Boris-Lawrie K. (2003) Primary sequence and secondary structure motifs in spleen necrosis virus RU5 confer translational utilization of unspliced human immunodeficiency virus type 1 reporter RNA. J Virol 77: 11973–11984.
80. Bolinger C, Yilmaz A, Hartman TR, et al. (2007) RNA helicase A interacts with divergent lymphotropic retroviruses and promotes translation of human T-cell leukemia virus type 1. Nucl Acid Res 35: 2629–2642.
81. Dangel AW, Hull S, Roberts TM, et al. (2002) Nuclear interactions are necessary for translational enhancement by spleen necrosis virus RU5. J Virol 76: 3292–3300.
82. Roberts TM, Boris-Lawrie K. (2000) The 5' RNA terminus of spleen necrosis virus stimulates translation of nonviral mRNA. J Virol 74: 8111–8118.
83. Reddy TR, Xu W, Mau JK, et al. (1999) Inhibition of HIV replication by dominant negative mutants of Sam68, a functional homolog of HIV-1 Rev. Nat Med 5: 635–642.
84. Marsh K, Soros V, Cochrane A. (2008) Selective translational repression of HIV-1 RNA by Sam68DeltaC occurs by altering PABP1 binding to unspliced viral RNA. Retrovirology 5: 97.
85. Sanchez-Velar N, Udofia EB, Yu Z, et al. (2004) RIP, a cellular cofactor for Rev function, promotes release of HIV RNAs from the perinuclear region. Genes Dev 18: 23–34.
86. Yu Z, Sanchez-Velar N, Catrina IE, et al. (2005) The cellular HIV-1 Rev cofactor hRIP is required for viral replication. Proc Natl Acad Sci USA 102: 4027–4032.
87. Woolaway K, Asai K, Emili A, et al. (2007) hnRNP E1 and E2 have distinct roles in modulating HIV-1 gene expression. Retrovirology 4: 28.
88. Giorgi C, Moore MJ. (2007) The nuclear nurture and cytoplasmic nature of localized mRNPs. Semin Cell Dev Biol 18: 186–193.
89. Palacios IM. (2007) How does an mRNA find its way? Intracellular localisation of transcripts. Semin Cell Dev Biol 18: 163–170.
90. Black AC, Luo J, Chun S, et al. (1996) Specific binding of polypyrimidine tract binding protein and hnRNP A1 to HIV-1 CRS elements. Virus Genes 12: 275–285.
91. Mangus DA, Evans MC, Jacobson A. (2003) Poly(A)-binding proteins: Multifunctional scaffolds for the post-transcriptional control of gene expression. Genome Biol 4: 223.
92. Afonina E, Stauber R, Pavlakis GN. (1998) The human poly(A)-binding protein 1 shuttles between the nucleus and the cytoplasm. J Biol Chem 273: 13015–13021.
93. Jin J, Sturgeon T, Chen C, et al. (2007) Distinct intracellular trafficking of equine infectious anemia virus and human immunodeficiency virus type 1 Gag during viral assembly and budding revealed by bimolecular fluorescence complementation assays. J Virol 81: 11226–11235.
94. Swanson CM, Puffer BA, Ahmad KM, et al. (2004) Retroviral mRNA nuclear export elements regulate protein function and virion assembly. EMBO J 23: 2632–2640.
95. Swanson CM, Malim MH. (2006) Retrovirus RNA trafficking: From chromatin to invasive genomes. Traffic 7: 1440–1450.
96. Bahner I, Sumiyoshi T, Kagoda M, et al. (2007) Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication. Mol Ther 15: 76–85.
97. Clever JL, Parslow TG. (1997) Mutant human immunodeficiency virus type 1 genomes with defects in RNA dimerization or encapsidation. J Virol 71: 3407–3414.
98. Harrison GP, Miele G, Hunter E, et al. (1998) Functional analysis of the core human immunodeficiency virus type 1 packaging signal in a permissive cell line. J Virol 72: 5886–5896.
99. Houzet L, Paillart JC, Smagulova F, et al. (2007) HIV controls the selective packaging of genomic, spliced viral and cellular RNAs into virions through different mechanisms. Nucl Acid Res 35: 2695–2704.
100. D’Souza V, Summers MF. (2005) How retroviruses select their genomes. Nat Rev Microbiol 3: 643–655.
101. Richardson JH, Child LA, Lever AM. (1993) Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region. J Virol 67: 3997–4005.
102. Lucke S, Grunwald T, Uberla K. (2005) Reduced mobilization of Revresponsive element-deficient lentiviral vectors. J Virol 79: 9359–9362
103. Anson DS, Fuller M. (2003) Rational development of a HIV-1 gene therapy vector. J Gene Med 5: 829–838.
104. Cui Y, Iwakuma T, Chang LJ. (1999) Contributions of viral splice sites and cisregulatory elements to lentivirus vector function. J Virol 73: 6171–6176.
105. Mautino MR, Ramsey WJ, Reiser J, et al. (2000) Modified human immunodeficiency virus-based lentiviral vectors display decreased sensitivity to trans-dominant Rev. Hum Gene Ther 11: 895–908.
106. Brandt S, Blissenbach M, Grewe B, et al. (2007) Rev proteins of human and simian immunodeficiency virus enhance RNA encapsidation. PLoS Pathog 3: e54.
107. Greatorex JS, Palmer EA, Pomerantz RJ, et al. (2006) Mutation of the Revbinding loop in the human immunodeficiency virus 1 leader causes a replication defect characterized by altered RNA trafficking and packaging. J Gen Virol 87: 3039–3044.
108. Butsch M, Boris-Lawrie K. (2000) Translation is not required to generate virion precursor RNA in human immunodeficiency virus type 1-infected T cells. J Virol 74: 11531–11537.
109. Mautino MR, Keiser N, Morgan RA. (2000) Improved titers of HIV-based lentiviral vectors using the SRV-1 constitutive transport element. Gene Ther 7: 1421–1424.
110. Mautino MR, Keiser N, Morgan RA. (2001) Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev. J Virol 75: 3590–3599.
111. Oh T, Bajwa A, Jia G, et al. (2007) Lentiviral vector design using alternative RNA export elements. Retrovirology 4: 38.
112. Srinivasakumar N, Chazal N, Helga-Maria C, et al. (1997) The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines. J Virol 71: 5841–5848.
113. Srinivasakumar N, Schuening FG. (1999) A lentivirus packaging system based on alternative RNA transport mechanisms to express helper and gene transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery. J Virol 73: 9589–9598.